These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35075818)

  • 21. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings.
    Goyal A; Gupta S; Gupta Y; Tandon N
    Diabetes Metab Syndr; 2020; 14(5):753-756. PubMed ID: 32502958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia.
    Nair AM; Gopalan S; Rajendran V; Varadaraj P; Marappa L; Pandurangan V; Madhavan S; Mani R; Bhaskar E
    Monaldi Arch Chest Dis; 2022 Apr; 92(4):. PubMed ID: 35416000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
    Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non-severe coronavirus disease 2019.
    Numaguchi R; Kurajoh M; Hiura Y; Imai T; Morioka T; Saito M; Shiraishi S; Emoto M; Nishiguchi Y
    J Diabetes Investig; 2022 Oct; 13(10):1779-1787. PubMed ID: 35616179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
    Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
    Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of hospitalized COVID-19 patients with diabetes mellitus in East Java, Indonesia: A cross-sectional study.
    Triyono EA; Wahyuhadi J; Prajitno JH; Novida H; Siagian N; Cahyani C; Putri AT; Lusida MAP; Hidayat AA; Idamusaga KS; Intansari NI; Asmara J; Hadi A; Bandem IKMP
    F1000Res; 2022; 11():684. PubMed ID: 36016993
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
    Bode B; Garrett V; Messler J; McFarland R; Crowe J; Booth R; Klonoff DC
    J Diabetes Sci Technol; 2020 Jul; 14(4):813-821. PubMed ID: 32389027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.
    Xu AY; Wang SH; Duong TQ
    BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37295808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.
    Zhou W; Ye S; Wang W; Li S; Hu Q
    J Diabetes Res; 2020; 2020():3918723. PubMed ID: 33062712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.
    Zhang Y; Li H; Zhang J; Cao Y; Zhao X; Yu N; Gao Y; Ma J; Zhang H; Zhang J; Guo X; Liu X
    Diabetes Obes Metab; 2020 Aug; 22(8):1443-1454. PubMed ID: 32406594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.
    Tramunt B; Smati S; Coudol S; Wargny M; Pichelin M; Guyomarch B; Al-Salameh A; Amadou C; Barraud S; Bigot E; Bordier L; Borot S; Bourgeon M; Bourron O; Charrière S; Chevalier N; Cosson E; Fève B; Flaus-Furmaniuk A; Fontaine P; Galioot A; Gonfroy-Leymarie C; Guerci B; Lablanche S; Lalau JD; Larger E; Lasbleiz A; Laviolle B; Marre M; Munch M; Potier L; Prevost G; Renard E; Reznik Y; Seret-Bégué D; Sibilia P; Thuillier P; Vergès B; Gautier JF; Hadjadj S; Cariou B; Mauvais-Jarvis F; Gourdy P
    Eur J Endocrinol; 2021 Jul; 185(2):299-311. PubMed ID: 34085949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.
    Laurenzi A; Caretto A; Molinari C; Mercalli A; Melzi R; Nano R; Tresoldi C; Rovere Querini P; Ciceri F; Lampasona V; Bosi E; Scavini M; Piemonti L
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1009-e1019. PubMed ID: 34718627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: A two-center cohort study.
    Xiao F; Zhou YC; Zhang MB; Chen D; Peng SL; Tang HN; Li L; Tang CY; Liu JY; Li B; Zhou HD
    J Med Virol; 2022 May; 94(5):1967-1975. PubMed ID: 34967028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
    Coppelli A; Giannarelli R; Aragona M; Penno G; Falcone M; Tiseo G; Ghiadoni L; Barbieri G; Monzani F; Virdis A; Menichetti F; Del Prato S;
    Diabetes Care; 2020 Oct; 43(10):2345-2348. PubMed ID: 32788285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
    Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
    J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity.
    Liontos A; Biros D; Kavakli A; Matzaras R; Tsiakas I; Athanasiou L; Samanidou V; Konstantopoulou R; Vagias I; Panteli A; Pappa C; Kolios NG; Nasiou M; Pargana E; Milionis H; Christaki E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of readmission and mortality in adults with diabetes or stress hyperglycemia after initial hospitalization for COVID-19.
    Chaugule A; Howard K; Simonson DC; McDonnell ME; Garg R; Gopalakrishnan G; Mitri J; Lebastchi J; Palermo NE; Westcott G; Weinstock RS
    BMJ Open Diabetes Res Care; 2024 Jun; 12(3):. PubMed ID: 38937276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
    Charoenngam N; Alexanian SM; Apovian CM; Holick MF
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.